Nevirapine precautions published.
New instructions tell physicians who is most at risk for rare but serious side effects when starting this important drug.
D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000187:drug effects; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine